06/21/2019

NCBH develops guide and recommends LAMs as first time treatment option

The National Council for Behavioral Health's (NCBH) Guide to Long-acting Medications (LAM) is a call to Action for psychiatrists and other clinicians and behavioral health organizations to increase the use of long-acting medications and recommends LAMs be considered as first-time treatment option. Read More

06/21/2019

Long-acting antipsychotics help cut risk for arrest in patients with schizophrenia

News from the American Psychiatric Association

After initiation of treatment with long-acting injectable antipsychotics, the incidence of arrest decreased among patients with schizophrenia or schizoaffective disorder and a previous history of arrest during a 2-year follow-up period at a community mental health center, according to a poster presented at APA annual meeting. Read More

06/19/2019

OhioMHAS offers more buprenorphine waiver trainings

The Ohio Department of Mental Health and Addiction Services continues waiver trainings for medical providers. These trainings are 1.5 days and have been approved for CMEs. Food will be provided at no cost. Participants will receive a course manual and a $1,300 stipend for providers who obtain their waiver within 100 days post training. Read More

06/19/2019

Report recommends local strategies to address addiction crisis in Appalachian counties

The National Association of Counties (NACo) and the Appalachian Regional Commission (ARC) released the report, “Opioids in Appalachia: The Role of Counties in Reversing a Regional Epidemic,” in an effort to combat the opioid epidemic that has plagued Ohio and other states in the region. Read More

06/19/2019

Medical board rejects medical marijuana as treatment for opioid addiction

On June 12, citing a lack of scientific proof, the State Medical Board of Ohio voted against allowing physicians to recommend marijuana to treat opioid use disorder. Read More